Palliation in heart failure: When less and more are more

Abstract

Get full access to this article

View all access options for this article.

References

1. Croft JB , Giles WH , Pollard RA , et al.: Heart failure survival among older adults in the United States. Arch Int Med. 1999; 159: 505-510.

2. Ho KKL , Anderson KM , Kannel WB , et al.: Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993; 107-115.

3. Gillum RF : Epidemiology of heart failure in the United States. Am Heart J. 1993; 126: 1042-1047.

4. Flather MD , Yusuf S , Kuber L , et al.: Long-term ACE inhibitor therapy in patients with heart failure or left ventricular dysfunction: A systematic overview of data from individual patients. Lancet. 2000; 355: 1575-1581.

5. Metra M , Nodari S , D'Aloia A , et al.: A rationale for the use of beta-blockers as standard treatment for heart failure. Am Heart J. 2000; 139: 511-521

6. Baker DW , Einstadter D , Thomas C , et al.: Mortality trends for 23,505 Medicare patients hospitalized with heart failure in northeast Ohio, 1991-1997. Am Heart J. 2003; 146: 258-264.

7. Heiat A , Gross CP , Krumholz HM : Representation of the elderly, women and minorities in heart failure clinical trials. Arch Int Med 2002; 162: 1682-1688.

8. Masoudi FA , Havranek EP , Wolf P , et al.: Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003; 146: 250-257.

9. Hosenpud J : Immunosuppression in cardiac transplantation. N Engl J Med. 2005; 352: 2749-2750.

10.

10. Rose E , Gelijns A , Moskowitz A : Long term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001; 345: 1435-1443.

11.

11. Mehra M , Greenberg B : Caveat medicus! J Am Coll Cardiol. 2004; 43: 1145-1148.

12.

12. Hauptman PJ , Rector T , Wentworth D , et al.: Quality of life in advanced heart failure: Role of mitral regurgitation. Am Heart J. in press. 2006; 151: 213-218.

13.

13. Masoudi FA , Rumsfeld JS , Havranek EP , et al.: Age, functional capacity and health related quality of life in patients with heart failure. J Card Fail. 2004; 10: 368-373.

14.

14. Rabow MW , Dibble SL , Pantilat SZ , et al.: The Comprehensive Care Team: A randomized trial of outpatient palliative medicine consultation. Arch Int Med 2004; 164: 83-91.

15.

15. Hauptman PJ , Havranek EP : Integrating palliative care into heart failure care. Arch Int Med. 2005; 165: 374-378.

16.

16. Hunt SA , Baker DW , Chin MH , et al.: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Available at: http./www.acc.orgclinicallguidelineslfailurelhfindex.htm.

17.

17. Ewy GA : Inotropic infusions for chronic congestive heart failure: Medical miracles or misguided medicinals? J Am Coll Cardiol. 1999; 33: 572-575.

18.

18. Mikolajczak P , George A , Oliver D , et al.: Preliminary economic analysis of chronic continuous home inotropic therapy in end-stage heart failure: Insights from a multi-state Medicare database. J Card Fail. 2004; 10: S109-S109.

19.

19. Rich MW , Shore BL : Dobutamine for patients with end-stage heart failure in a hospice program. J Palliat Med. 2003; 6: 93-97.

20.

20. Kutner J , Goodlin SJ , Connor SR , et al.: Hospice care for heart failure patients. J Pain Sympt Mgmt. 2005; 29: 525-528.

21.

21. Moss AJ , Zareba W , Hall WJ , et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346: 877-883.

22.

22. Bardy GH : Amiodarone or implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.

23.

23. Goldstein NE , Lampert R , Bradley E , et al.: Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004; 141: 835-838.

24.

24. Jaagosild P , Dawson NV , Thomas C , et al. for the SUPPORT Investigators: Outcomes of acute exacerbation of severe congestive heart failure: Quality of life, resource use and survival: The Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatment. Arch Int Med. 1998; 158: 1081-1089.

25.

25. Krumholz HM , Phillips RS , Hamel MB , et al., for the SUPPORT Investigators: Resuscitation preferences among patients with severe congestive heart failure: Results from the SUPPORT project. Circulation. 1998; 98: 648-655.